{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T19:43:05Z","timestamp":1783539785187,"version":"3.55.0"},"reference-count":10,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["annallergy.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Allergy, Asthma & Immunology"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.anai.2021.02.016","type":"journal-article","created":{"date-parts":[[2021,2,24]],"date-time":"2021-02-24T02:37:57Z","timestamp":1614134277000},"page":"726-727","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Relapsing chronic eosinophilic pneumonia treated successfully with benralizumab"],"prefix":"10.1016","volume":"126","author":[{"given":"Peter A.","family":"Ricketti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony J.","family":"Ricketti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.anai.2021.02.016_bib1","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2500\/aap.2013.34.3628","article-title":"Primary eosinophilic lung diseases","volume":"34","author":"Rose","year":"2013","journal-title":"Allergy Asthma Proc"},{"issue":"3","key":"10.1016\/j.anai.2021.02.016_bib2","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.ccm.2016.04.015","article-title":"Eosinophilic lung diseases","volume":"37","author":"Cottin","year":"2016","journal-title":"Clin Chest Med"},{"issue":"17","key":"10.1016\/j.anai.2021.02.016_bib3","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.2169\/internalmedicine.55.6765","article-title":"The long-term clinical course of chronic eosinophilic pneumonia","volume":"55","author":"Ishiquro","year":"2016","journal-title":"Intern Med"},{"issue":"3","key":"10.1016\/j.anai.2021.02.016_bib4","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.alit.2017.12.004","article-title":"Long-term management and persistent impairment of pulmonary function in chronic eosinophilic pneumonia: a review of the previous literature","volume":"67","author":"Suzuki","year":"2018","journal-title":"Allergol Int"},{"issue":"4 Pt 1","key":"10.1016\/j.anai.2021.02.016_bib5","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1164\/ajrccm.153.4.8616578","article-title":"Cytokine production at the site of disease in chronic eosinophilic pneumonitis","volume":"153","author":"Kita","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.anai.2021.02.016_bib6","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1378\/chest.11-1881","article-title":"Omalizumab as a steroid-sparing agent in chronic eosinophilic pneumonia","volume":"142","author":"Kaya","year":"2012","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.anai.2021.02.016_bib7","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1080\/02770903.2018.1543434","article-title":"Anti-interleukin (IL-5) as a steroid-sparing agent in chronic eosinophilic pneumonia","volume":"57","author":"Sarkis","year":"2020","journal-title":"J\u00a0Asthma"},{"issue":"5","key":"10.1016\/j.anai.2021.02.016_bib8","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1016\/j.jaip.2018.06.017","article-title":"A\u00a0case of chronic eosinophilic pneumonia successfully treated with mepolizumab","volume":"6","author":"To","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"9","key":"10.1016\/j.anai.2021.02.016_bib9","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.2169\/internalmedicine.3606-19","article-title":"Promising effects of benralizumab on chronic eosinophilic pneumonia","volume":"59","author":"Isomoto","year":"2020","journal-title":"Intern Med"},{"issue":"2","key":"10.1016\/j.anai.2021.02.016_bib10","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/ACI.0000000000000251","article-title":"Interleukin-5 pathway inhibition in the treatment of eosinophilic respiratory disorders: evidence and unmet needs","volume":"16","author":"Vanricchi","year":"2016","journal-title":"Curr Opin Allergy Clin Immunol"}],"container-title":["Annals of Allergy, Asthma & Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120621001344?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120621001344?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T13:26:26Z","timestamp":1761053186000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1081120621001344"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":10,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S1081120621001344"],"URL":"https:\/\/doi.org\/10.1016\/j.anai.2021.02.016","relation":{},"ISSN":["1081-1206"],"issn-type":[{"value":"1081-1206","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Relapsing chronic eosinophilic pneumonia treated successfully with benralizumab","name":"articletitle","label":"Article Title"},{"value":"Annals of Allergy, Asthma & Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anai.2021.02.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}